Balancing the Risk-Benefit Ratio of Immune Checkpoint Inhibitor and Anti-VEGF Combination Therapy in Renal Cell Carcinoma: A Systematic Review and Meta-AnalysisTao Li, Jiannan Yao, Guangyu An et al.|Frontiers in Oncology|2021Cited by 12
Livin Regulates H2A.XY142 Phosphorylation and Promotes Autophagy in Colon Cancer Cells via a Novel Kinase ActivityYang Ge, Shuqiang Li|Frontiers in Oncology|2019Cited by 1